SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000899140-22-000492
Filing Date
2022-05-02
Accepted
2022-05-02 17:04:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE DFAN14A - DEFINITIVE ADDITIONAL MATERIALS k52696835a.htm DFAN14A 15318
2 FORM OF LETTER TO SHAREHOLDERS, DATED MAY 2, 2022 k52696835b.htm EX-99.1 13506
  Complete submission text file 0000899140-22-000492.txt   30040
Mailing Address
Business Address
KAYNE RICHARD A (Filed by) CIK: 0000884413 (see all company filings)

Type: DFAN14A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-39503 | Film No.: 22883022
SIC: 2836 Biological Products, (No Diagnostic Substances)